APPLICATION OF A HIGH-THROUGHPUT OPTIMIZATION PLATFORM IN ACUTE MYELOID LEUKEMIA

APPLICATION OF A HIGH-THROUGHPUT OPTIMIZATION PLATFORM IN ACUTE MYELOID LEUKEMIA

Ph.D

Saved in:

Bibliographic Details
Main Author:	NOOR RASHIDHA BINTE MEERA SAHIB
Other Authors:	DEAN'S OFFICE (MEDICINE)
Format:	Theses and Dissertations
Language:	English
Published:	2024
Subjects:	Acute Myeloid Leukemia, Quadratic Phenotypic Optimization Platform (QPOP), precision medicine, hemato-oncology, drug resistance, flow cytometry
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/248502
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Similar Items

Characterisation of the effects and mechanism of action of rapamycin and genistein on acute myeloid leukemia using high-throughput techniques
by: KARTHIK NARASIMHAN
Published: (2011)

Survival of childhood leukemia in Singapore
by: Quah, T.C., et al.
Published: (2013)

In vitro and in vivo study of ABT-869 in treatment acute myeloid leukemia (AML) alone or in combination with chemotherapy or HDAC inhibitors: insight into molecular mechanism and biologic characterization
by: ZHOU JIANBIAO
Published: (2010)

In vivo efficacy of a novel liposomal formulation of safingol in the treatment of acute myeloid leukemia
by: Tan, K.-B., et al.
Published: (2014)

Parenteral glutamine-dipeptide supplementation in acute myeloid leukemia patients receiving chemotherapy : effects on neutrophil functions, prevention of chemotherapy-induced side effects and impact on cost-effectiveness
by: Chuleegone Sornsuvit
Published: (2023)

X-linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery
by: Zhou, J., et al.
Published: (2021)

Establishment of a Detecting Procedure and Analysis of CEBPA-TAD Genetic Mutation in Vietnamese Acute Myeloid Leukemia Patients
by: Bui, Thuy Huong, et al.
Published: (2018)

LIPOSOMAL FORMULATION OF RATIONAL COMBINATION OF BIOACTIVE LIPIDS FOR THE TREATMENT OF LEUKEMIA
by: TAN KUAN BOONE
Published: (2013)

Wilms Tumor 1 Mutations Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia
by: Wang, Yin, et al.
Published: (2022)

Autologous bone marrow transplantation in a child with acute promyelocytic leukemia in second remission
by: Quah, T.C., et al.
Published: (2013)

Bilineal T lymphoblastic and myeloid blast transformation in chronic myeloid leukemia with TP53 mutation-an uncommon presentation in adults
by: Krishnan, S., et al.
Published: (2016)

RESISTANCE TO FLT3 INHIBITORS IN ACUTE MYELOID LEUKEMIA: MOLECULAR MECHANISMS AND RESENSITIZING STRATEGIES
by: Zhou, J, et al.
Published: (2019)

Single-cell genomic profiling of acute myeloid leukemia for clinical use: A pilot study
by: Yan, Benedict, et al.
Published: (2022)

Quercetin Induces Apoptosis via Downregulation of Vascular Endothelial Growth Factor/Akt Signaling Pathway in Acute Myeloid Leukemia Cells
by: Shi, H., et al.
Published: (2021)

A PRE-LEUKEMIC DNA METHYLATION STATE IN HEALTHY INDIVIDUAL ASSOCIATED WITH RISK OF MYELOID MALIGNANCY
by: LAO ZHENTANG
Published: (2021)

Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia
by: Forshed, J., et al.
Published: (2011)

An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia
by: Her Z., et al.
Published: (2020)

ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia.
by: Zhou, Jianbiao, et al.
Published: (2022)

Corrigendum: Quercetin Induces Apoptosis Via Downregulation of VEGF/Akt Signaling Pathway in Acute Myeloid Leukemia Cells (Frontiers in Pharmacology, (2020), 11, 10.3389/fphar.2020.534171)
by: Shi, Huan, et al.
Published: (2022)

EVALUATION OF CELLULAR RESPONSE, RESISTANCE AND COMBINATORIAL THERAPY WITH VINCRISTINE IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
by: KOH SHIMIN, GRACE
Published: (2020)

In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor
by: Zhou, J., et al.
Published: (2011)

In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor
by: Zhou, J., et al.
Published: (2011)

In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor
by: Zhou, J., et al.
Published: (2011)

CD137L Signalling induces Differentiation of Primary Acute Myeloid Leukemia Cells
by: CHENG CHEONG KIN
Published: (2014)

NF-kappa B promotes the stem-like properties of leukemia cells by activation of LIN28B
by: Zhou, Jianbiao, et al.
Published: (2022)

C/EBPβ promotes BCR-ABL-mediated myeloid expansion and leukemic stem cell exhaustion
by: Hayashi, Y., et al.
Published: (2016)

SRRM2 organizes splicing condensates to regulate alternative splicing
by: Xu, Shaohai, et al.
Published: (2023)

Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients
by: Sadudee Chotirat, et al.
Published: (2017)

Ponatinib analogues: Virtual screening, precursor, synthesis, and approaches in the preparation of selected compounds
by: Padilla, Vince Lambert H.
Published: (2020)

Chromosomal aberrations and molecular changes in BCR-ABL gene in Chronic Myelogenous Leukemia (CML) patients undergoing chemotherapy
by: Soriano-Abad, Ma. Celeste S.
Published: (2010)

Variation in the seasonal diagnosis of acute lymphoblastic leukemia: Evidence from Singapore, the United States, and Sweden
by: Gao, F., et al.
Published: (2014)

Liquid biopsy for minimal residual disease detection in leukemia using a portable blast cell biochip
by: Khoo, Bee Luan, et al.
Published: (2022)

ZAP-70 Expression and its Prognostic Significance in Childhood B-lineage Acute Lymphoblastic Leukemia
by: Karan Paisooksantivatana, et al.
Published: (2022)

Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish
by: Lu, J.-W, et al.
Published: (2020)

Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis
by: Guo, Mingrui, et al.
Published: (2023)

GLOBALLY OPTIMIZING THERAPEUTIC COMBINATIONS USING QUANTITATIVE PARABOLIC OPTIMIZATION PLATFORM (QPOP)
by: MASTURAH BTE MOHD ABDUL RASHID
Published: (2018)

Study on properties of native and cultured leukemic cells with special reference to the diagnosis and prognosis of acute myelogenous leukemia
by: Pimpawan Patmasiriwat
Published: (2023)

ROLE OF NOTCH AND JAK/STAT SIGNALING PATHWAYS IN ACUTE MEGAKARYOBLASTIC LEUKEMIA
by: KELLY ONG OOI KEE
Published: (2015)

Acute lymphoblastic leukemia with the phenotype of a putative B-cell/T-cell bipotential precursor
by: Lau, L.G., et al.
Published: (2016)

The role of protein phosphorylation in therapy resistance and disease progression in chronic myelogenous leukemia
by: Juan, W.C., et al.
Published: (2016)